-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
ABVC BIOPHARMA, INC. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2016 to Q4 2024.
- ABVC BIOPHARMA, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was -$226K, a 60.6% decline year-over-year.
- ABVC BIOPHARMA, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $451K, a 50% decline year-over-year.
- ABVC BIOPHARMA, INC. annual Share-based Payment Arrangement, Expense for 2024 was $451K, a 50% decline from 2023.
- ABVC BIOPHARMA, INC. annual Share-based Payment Arrangement, Expense for 2023 was $903K, a 87.2% decline from 2022.
- ABVC BIOPHARMA, INC. annual Share-based Payment Arrangement, Expense for 2022 was $7.04M, a 32.6% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)